Trial Alerts: Now Available on Metastatic Trial Search!
We are excited to announce that Trial Alerts are now available on Metastatic Trial Search! Trial Alerts are emails sent once a week when new trials posted on...
Read MoreManaging Side Effects of ADCs
With three ADCs approved for MBC and new ADCs being studied in clinical trials, an important question is how to reduce side effects of these drugs. Side effects...
Read MoreLeptomeningeal Disease: How is it Different from Brain Metastasis and How is it Treated?
Breast cancer can spread to the brain, called brain metastasis. However, breast cancer can also spread to the layers of tissue that line and protect the brain,...
Read MoreWhat is “Drug Sequencing”?
Researchers are continually developing new drugs to treat MBC and understanding how to best use drugs already approved for MBC. An important question in treatment...
Read MoreDecoding Clinical Trial Terms: Dose Escalation and Dose Expansion
If you are considering enrolling in a clinical trial and/or are reading clinical trial results, you may see unfamiliar terms about different types of clinical...
Read MoreOur New Partner: CancerBuddy
Our newest Metastatic Trial Search partner is CancerBuddy, which is an app that provides support to people living with cancer by connecting them to people with a...
Read MoreExperts Break Down Important MBC Research from SABCS 2023
The San Antonio Breast Cancer Symposium (SABCS) 2023 was held in December 2023. Many important studies about MBC were presented. Click below to see videos and...
Read MoreDiscovering New Ways to Overcome Treatment Resistance in Triple-Negative MBC
Treatment resistance is when cancer does not respond to a drug. Cancer, including triple-negative MBC, often becomes resistant to a particular treatment over...
Read MoreMark Your 2024 Calendars!
Conferences take place throughout the US and other countries throughout the year that are relevant to women and men with metastatic breast cancer. Many of these...
Read MoreSEARCH OUR SITE
for past articles or specific information.